Saltar al contenido
Merck

Contraction and AICAR stimulate IL-6 vesicle depletion from skeletal muscle fibers in vivo.

Diabetes (2013-06-14)
Hans P M M Lauritzen, Josef Brandauer, Peter Schjerling, Ho-Jin Koh, Jonas T Treebak, Michael F Hirshman, Henrik Galbo, Laurie J Goodyear
RESUMEN

Recent studies suggest that interleukin 6 (IL-6) is released from contracting skeletal muscles; however, the cellular origin, secretion kinetics, and signaling mechanisms regulating IL-6 secretion are unknown. To address these questions, we developed imaging methodology to study IL-6 in fixed mouse muscle fibers and in live animals in vivo. Using confocal imaging to visualize endogenous IL-6 protein in fixed muscle fibers, we found IL-6 in small vesicle structures distributed throughout the fibers under basal (resting) conditions. To determine the kinetics of IL-6 secretion, intact quadriceps muscles were transfected with enhanced green fluorescent protein (EGFP)-tagged IL-6 (IL-6-EGFP), and 5 days later anesthetized mice were imaged before and after muscle contractions in situ. Contractions decreased IL-6-EGFP-containing vesicles and protein by 62% (P < 0.05), occurring rapidly and progressively over 25 min of contraction. However, contraction-mediated IL-6-EGFP reduction was normal in muscle-specific AMP-activated protein kinase (AMPK) α2-inactive transgenic mice. In contrast, the AMPK activator AICAR decreased IL-6-EGFP vesicles, an effect that was inhibited in the transgenic mice. In conclusion, resting skeletal muscles contain IL-6-positive vesicles that are expressed throughout myofibers. Contractions stimulate the rapid reduction of IL-6 in myofibers, occurring through an AMPKα2-independent mechanism. This novel imaging methodology clearly establishes IL-6 as a contraction-stimulated myokine and can be used to characterize the secretion kinetics of other putative myokines.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranosyl 5′-monophosphate, ≥93%
Supelco
5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranosyl 5′-monophosphate, analytical standard